Advances in Liposomes-Based-Therapeutics as Cutting-Edge for Ocular Fungal Infections: An Updated Review

H Mehendiratta, S Singh, N Sharma, L Kishore… - BioNanoScience, 2024 - Springer
The drug delivery through the eye has been challenging due to the complex physiology of
the eye. The ocular region is commonly considered the most advantageous site for the …

A recent update on therapeutic potential of vesicular system against fungal keratitis

SN Sanap, A Kedar, AC Bisen, S Agrawal… - Journal of Drug Delivery …, 2022 - Elsevier
Fungal keratitis (FK) is a highly invasive and challenging corneal infection that can be
deadly if not treated well. Aspergillus, Fusarium, and Candida are the most common …

Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review

L Kumar, S Verma, A Bhardwaj, S Vaidya… - Artificial cells …, 2014 - Taylor & Francis
During the last two decades, the occurrence of fungal infections either superficial or systemic
has been increasing. Moreover, fungal infections become more difficult to treat when they …

[HTML][HTML] Formulation Considerations and Application of Nanostructured Lipid Carriers (NLC) for Ocular Delivery

S Kumari, S Jaiswal, A Kamboj - Journal of Young Pharmacists, 2023 - jyoungpharm.org
Fungal infection associated with eye annually affects more than one ten lakh people
globally. It can affect vision and sometimes causes complete blindness. Drug delivery …

Liposomes and nanotechnology in drug development: focus on ocular targets

M Honda, T Asai, N Oku, Y Araki… - International journal …, 2013 - Taylor & Francis
Poor drug delivery to lesions in patients' eyes is a major obstacle to the treatment of ocular
diseases. The accessibility of these areas to drugs is highly restricted by the presence of …

Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection

JJ López-Cano… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: The development of ophthalmic formulations able to deliver hydrophilic and
hydrophobic drugs to the inner structures of the eye and restore the preocular tear film has …

Ten years of knowledge of nano-carrier based drug delivery systems in ophthalmology: current evidence, challenges, and future prospective

J Zhang, J Jiao, M Niu, X Gao, G Zhang… - International Journal …, 2021 - Taylor & Francis
The complex drug delivery barrier in the eye reduces the bioavailability of many drugs,
resulting in poor therapeutic effects. It is necessary to investigate new drugs through …

Development of lactoferrin-loaded liposomes for the management of dry eye disease and ocular inflammation

A López-Machado, N Díaz-Garrido, A Cano, M Espina… - Pharmaceutics, 2021 - mdpi.com
Dry eye disease (DED) is a high prevalent multifactorial disease characterized by a lack of
homeostasis of the tear film which causes ocular surface inflammation, soreness, and visual …

Lipid-based nanocarriers for ocular drug delivery: An updated review

B Das, AK Nayak, S Mallick - Journal of Drug Delivery Science and …, 2022 - Elsevier
Recent years have witnessed a boom in ocular nanomedicine research with a number of
lipid-based nanocarriers such as liposomes, niosomes, cubosomes, nanoemulsions, solid …

Review of Nanoformulations for Treating Ocular Fungal Infections

AL Onugwu, SC Emencheta, RN Sabastine… - Journal of Drug Delivery …, 2024 - Elsevier
Ocular fungal infections affect more than one million people globally, of which fungal
keratitis and endophthalmitis are the most common. These infections are the primary cause …